Investigation on Rebleeding Risk Factors in Obscure Gastrointestinal Bleeding Patients after Capsule Endoscopy
10.3969/j.issn.1008-7125.2015.08.003
- VernacularTitle:不明原因消化道出血患者胶囊内镜检查后再出血的危险因素探讨
- Author:
Zhuwen YU
;
Kunting XIAO
;
Xiaoming XU
;
Chenfei ZHANG
;
Weichang CHEN
- Publication Type:Journal Article
- Keywords:
Obscure Gastrointestinal Bleeding;
Capsule Endoscopy;
Risk Factors;
Rebleeding
- From:
Chinese Journal of Gastroenterology
2015;(8):462-466
- CountryChina
- Language:Chinese
-
Abstract:
Background:Because of its non-invasiveness,direct inspection,and high detection rate,capsule endoscopy(CE) has been accepted as the first-line examination for diagnosis of obscure gastrointestinal bleeding(OGIB). However,no matter the result of CE is positive or negative,it is unable to accurately predict the occurrence of rebleeding. Aims:To preliminarily investigate the related risk factors of rebleeding in OGIB patients with positive or negative CE for reducing the rebleeding rate. Methods:One hundred and sixteen OGIB patients undergone CE and with follow-up data from October 2009 to October 2013 at the First Affiliated Hospital of Soochow University were recruited,the rebleeding rate of patients with positive and negative CE,and the risk factors of rebleeding were analyzed. Results:CE diagnostic rate was 56. 9% , and the overall rebleeding rate was 37. 9% . The rebleeding rate in CE positive patients was significantly higher than that in CE negative patients(48. 5% vs. 24. 0% ,P < 0. 01). Male,age ≥50 years,hypertension,accumulated bleeding ≥500 mL within 3 months before CE were the independent risk factors of increase in rebleeding rate in CE positive patients. Age≥50 years,abnormal blood coagulation,without specific treatment were the independent risk factors of increase in rebleeding rate in CE negative patients. Conclusions:Followed-up should be performed in OGIB patients with risk factors of rebleeding for at least 24 months after CE. Repeated examination can be avoided in OGIB patients without risk factors.